newsfilter
← Latest News
GlobeNewswire·

Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil

MONTREAL and CHARLOTTE, N.C., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of innovative